1. Home
  2. ELEV vs SIF Comparison

ELEV vs SIF Comparison

Compare ELEV & SIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELEV
  • SIF
  • Stock Information
  • Founded
  • ELEV 2019
  • SIF 1913
  • Country
  • ELEV United States
  • SIF United States
  • Employees
  • ELEV N/A
  • SIF N/A
  • Industry
  • ELEV Biotechnology: Pharmaceutical Preparations
  • SIF Office Equipment/Supplies/Services
  • Sector
  • ELEV Health Care
  • SIF Industrials
  • Exchange
  • ELEV Nasdaq
  • SIF Nasdaq
  • Market Cap
  • ELEV 22.6M
  • SIF 23.1M
  • IPO Year
  • ELEV 2021
  • SIF N/A
  • Fundamental
  • Price
  • ELEV $0.38
  • SIF $4.99
  • Analyst Decision
  • ELEV Hold
  • SIF
  • Analyst Count
  • ELEV 6
  • SIF 0
  • Target Price
  • ELEV $1.77
  • SIF N/A
  • AVG Volume (30 Days)
  • ELEV 938.5K
  • SIF 29.7K
  • Earning Date
  • ELEV 08-05-2025
  • SIF 08-11-2025
  • Dividend Yield
  • ELEV N/A
  • SIF N/A
  • EPS Growth
  • ELEV N/A
  • SIF N/A
  • EPS
  • ELEV N/A
  • SIF N/A
  • Revenue
  • ELEV N/A
  • SIF $83,554,000.00
  • Revenue This Year
  • ELEV N/A
  • SIF N/A
  • Revenue Next Year
  • ELEV N/A
  • SIF N/A
  • P/E Ratio
  • ELEV N/A
  • SIF N/A
  • Revenue Growth
  • ELEV N/A
  • SIF 35.83
  • 52 Week Low
  • ELEV $0.22
  • SIF $2.33
  • 52 Week High
  • ELEV $3.28
  • SIF $5.96
  • Technical
  • Relative Strength Index (RSI)
  • ELEV 54.73
  • SIF 76.91
  • Support Level
  • ELEV $0.36
  • SIF $3.90
  • Resistance Level
  • ELEV $0.38
  • SIF $4.34
  • Average True Range (ATR)
  • ELEV 0.01
  • SIF 0.34
  • MACD
  • ELEV -0.00
  • SIF 0.11
  • Stochastic Oscillator
  • ELEV 53.93
  • SIF 100.00

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.

About SIF SIFCO Industries Inc.

SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.

Share on Social Networks: